Probing the Dynamic Structure–Function and Structure-Free Energy Relationships of the Coronavirus Main Protease with Biodynamics Theory
- Hongbin Wan
Hongbin WanGlobal Discovery Chemistry, Computer-Aided Drug Discovery, Novartis Institutes for BioMedical Research, 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United StatesMore by Hongbin Wan
- ,
- Vibhas Aravamuthan
Vibhas AravamuthanVibhas Aravamuthan – NIBR Informatics, Novartis Institutes for BioMedical Research, 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United StatesMore by Vibhas Aravamuthan
- , and
- Robert A. Pearlstein*
Robert A. Pearlstein*Email: [email protected]Global Discovery Chemistry, Computer-Aided Drug Discovery, Novartis Institutes for BioMedical Research, 181 Massachusetts Avenue, Cambridge, Massachusetts 02139, United StatesMore by Robert A. Pearlstein
Abstract
The SARS-CoV-2 main protease (Mpro) is of major interest as an antiviral drug target. Structure-based virtual screening efforts, fueled by a growing list of apo and inhibitor-bound SARS-CoV/CoV-2 Mpro crystal structures, are underway in many laboratories. However, little is known about the dynamic enzyme mechanism, which is needed to inform both assay development and structure-based inhibitor design. Here, we apply biodynamics theory to characterize the structural dynamics of substrate-induced Mpro activation under nonequilibrium conditions. The catalytic cycle is governed by concerted dynamic structural rearrangements of domain 3 and the m-shaped loop (residues 132–147) on which Cys145 (comprising the thiolate nucleophile and half of the oxyanion hole) and Gly143 (comprising the second half of the oxyanion hole) reside. In particular, we observed the following: (1) Domain 3 undergoes dynamic rigid-body rotation about the domain 2–3 linker, alternately visiting two primary conformational states (denoted as M1pro ↔ M2pro); (2) The Gly143-containing crest of the m-shaped loop undergoes up and down translations caused by conformational changes within the rising stem of the loop (Lys137–Asn142) in response to domain 3 rotation and dimerization (denoted as M1/downpro ↔ 2·M2/uppro) (noting that the Cys145-containing crest is fixed in the up position). We propose that substrates associate to the M1/downpro state, which promotes the M2/downpro state, dimerization (denoted as 2·M2/uppro–substrate), and catalysis. Here, we explore the state transitions of Mpro under nonequilibrium conditions, the mechanisms by which they are powered, and the implications thereof for efficacious inhibition under in vivo conditions.
Cited By
This article is cited by 8 publications.
- Elena K. Schneider-Futschik. Chronic Lung and Respiratory Conditions Affecting Lungs and Airways. ACS Pharmacology & Translational Science 2022, 5 (9) , 692-693. https://doi.org/10.1021/acsptsci.2c00138
- Andrei A. Golosov Alec N. Flyer Lauren G. Monovich . Design and Discovery of Orally Bioavailable Macrocycles: Toward Orally Bioavailable Peptide Therapeutics. , 199-222. https://doi.org/10.1021/bk-2022-1417.ch008
- Eunice Cho, Margarida Rosa, Ruhi Anjum, Saman Mehmood, Mariya Soban, Moniza Mujtaba, Khair Bux, Syed T. Moin, Mohammad Tanweer, Sarath Dantu, Alessandro Pandini, Junqi Yin, Heng Ma, Arvind Ramanathan, Barira Islam, Antonia S. J. S. Mey, Debsindhu Bhowmik, Shozeb Haider. Dynamic Profiling of β-Coronavirus 3CL Mpro Protease Ligand-Binding Sites. Journal of Chemical Information and Modeling 2021, 61 (6) , 3058-3073. https://doi.org/10.1021/acs.jcim.1c00449
- Rafael E. O. Rocha, Elton J. F. Chaves, Pedro H. C. Fischer, Leon S. C. Costa, Igor Barden Grillo, Luiz E. G. da Cruz, Fabiana C. Guedes, Carlos H. da Silveira, Marcus T. Scotti, Alex D. Camargo, Karina S. Machado, Adriano V. Werhli, Rafaela S. Ferreira, Gerd B. Rocha, Leonardo H. F. de Lima. A higher flexibility at the SARS-CoV-2 main protease active site compared to SARS-CoV and its potentialities for new inhibitor virtual screening targeting multi-conformers. Journal of Biomolecular Structure and Dynamics 2022, 40 (19) , 9214-9234. https://doi.org/10.1080/07391102.2021.1924271
- Mohammad Khedri, Reza Maleki, Mohammad Dahri, Mohammad Moein Sadeghi, Sima Rezvantalab, Hélder A. Santos, Mohammad-Ali Shahbazi. Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations. Drug Delivery and Translational Research 2022, 12 (6) , 1408-1422. https://doi.org/10.1007/s13346-021-01054-w
- Emanuele Fornasier, Maria Ludovica Macchia, Gabriele Giachin, Alice Sosic, Matteo Pavan, Mattia Sturlese, Cristiano Salata, Stefano Moro, Barbara Gatto, Massimo Bellanda, Roberto Battistutta. A new inactive conformation of SARS-CoV-2 main protease. Acta Crystallographica Section D Structural Biology 2022, 78 (3) , 363-378. https://doi.org/10.1107/S2059798322000948
- Shafi Mahmud, Md. Robiul Hasan, Suvro Biswas, Gobindo Kumar Paul, Shamima Afrose, Mohsana Akter Mita, Mst. Sharmin Sultana Shimu, Maria Meha Promi, Umme Hani, Mohamed Rahamathulla, Md. Arif Khan, Shahriar Zaman, Md. Salah Uddin, Mohammed Rahmatullah, Rownak Jahan, Ali M. Alqahtani, Md. Abu Saleh, Talha Bin Emran. Screening of Potent Phytochemical Inhibitors Against SARS-CoV-2 Main Protease: An Integrative Computational Approach. Frontiers in Bioinformatics 2021, 1 https://doi.org/10.3389/fbinf.2021.717141
- Robert A. Pearlstein, Hongbin Wan, Vibhas Aravamuthan. Toward in vivo relevant drug design. Drug Discovery Today 2021, 26 (3) , 637-650. https://doi.org/10.1016/j.drudis.2020.10.012